SESEN BIO INC (SESN)
US8177631053 - Common Stock
Sesen Bio stockholders approve 1-for-20 reverse stock split (NASDAQ:SESN)
Sesen Bio (SESN) stockholders on Thursday approved effecting a 1-for-20 reverse stock split of the company's issued and outstanding shares. Read more here.
Sesen Bio wins shareholder approval for Carisma merger (NASDAQ:SESN)
Sesen Bio (SESN) announced Thursday that its shareholders greenlighted the company’s pending merger with Carisma Therapeutics at a special stockholder meeting. Read the full story here.
Sesen Bio Stockholders Approve Merger with Carisma Therapeutics
Sesen Bio Reports Fourth Quarter and Full-Year 2022 Financial Results
SHAREHOLDER ALERT: Weiss Law Reminds SESN, MLVF, VLON, and SHBI Shareholders About Its Ongoing Investigations
/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...
Sesen Bio to Host Webcast with Carisma Therapeutics to Discuss Pending Merger
SHAREHOLDER ALERT: Weiss Law Reminds SESN, MLVF, VLON, and APEN Shareholders About Its Ongoing Investigations
/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...
BML, One of Sesen Bio’s Top Stockholders, Announces Support for Pending Merger with Carisma Therapeutics
SESN stock gains on amended terms for merger with Carisma (NASDAQ:SESN)
Sesen Bio (SESN) added ~11% pre-market Tuesday after an agreement with two key shareholders to obtain support for its pending merger with Carisma Therapeutics. Read the full story here.
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SESN, LMST, SAL
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
SHAREHOLDER ALERT: Weiss Law Reminds SESN, MLVF, VLON, and APEN Shareholders About Its Ongoing Investigations
/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...
Sesen Bio Files Investor Presentation in Connection with Pending Carisma Therapeutics Merger
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ANGN, SAFE, SESN, LMST
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
SHAREHOLDER ALERT: Weiss Law Reminds SESN, MLVF, VLON, and APEN Shareholders About Its Ongoing Investigations
/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...
Sesen Bio receives Nasdaq delisting notice (NASDAQ:SESN)
Sesen Bio (SESN) has received a Nasdaq delisting notice as its share price has fallen below $1.
Sesen Bio Receives NASDAQ Delisting Notice
Sesen Bio Reiterates Confidence that Pending Merger with Carisma is in Best Interests of Stockholders
Investor Group Issues Letter to the Boards of Sesen Bio and Carisma Rejecting Their Apparent Attempt to Purchase Merger Support
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MAXR, SESN, IMRA, ELVT
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
SHAREHOLDER ALERT: Weiss Law Reminds DCT, PAYA, DCP, and SESN Shareholders About Its Ongoing Investigations
/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...
SHAREHOLDER ALERT: Weiss Law Reminds DCP, SESN, MLVF, and VLON Shareholders About Its Ongoing Investigations
/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...
SHAREHOLDER ALERT: Weiss Law Reminds SESN, MLVF, VLON, and APEN Shareholders About Its Ongoing Investigations
/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...
Investor Group Issues Letter to Sesen Bio’s Board of Directors Regarding Intent to Vote AGAINST Proposed Carisma Merger
Sesen Bio Reiterates Confidence in Pending Merger with Carisma Therapeutics
Sesen Bio investors plan to vote against Carisma merger(NASDAQ:SESN)
Sesen Bio (SESN) investors reiterated their plan to vote against the merger with Carisma Therapuetics, calling it a an "illogical, value-destructive" deal. Sesen rose 4.2%.Bradley L
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates APEN, HZNP, SESN
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...